PeerVoice Internal Medicine Video

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 371 Folge(n) erschienen. .

Gesamtlänge aller Episoden: 5 days 19 hours 19 minutes

subscribe
share





Can Long-Acting Injectables Make a Difference in HIV?


Can Long-Acting Injectables Make a Difference in HIV?


share







   25m
 
 

Optimising Standard of Care for Patients With Axial Spondyloarthropathies: Why Gender Matters!


Optimising Standard of Care for Patients With Axial Spondyloarthropathies: Why Gender Matters!


share







   23m
 
 

Patient-Centred Approaches to Better Care in Psoriasis: Challenges and Solutions


Patient-Centred Approaches to Better Care in Psoriasis: Challenges and Solutions


share







   18m
 
 

Optimising HBV Treatment Outcomes Whilst We Hunt for a Cure


Optimising HBV Treatment Outcomes Whilst We Hunt for a Cure


share







   18m
 
 

Understanding Hypercapnia in Adult Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes


Understanding Hypercapnia in Adult Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes


share







 2021-03-12  13m
 
 

Expert Perspectives on Disease Progression in Axial Spondyloarthritis


Expert Perspectives on Disease Progression in Axial Spondyloarthritis


share







 2021-03-10  20m
 
 

Let Their Feet Lead the Way: Tools for Early Identification of FOP


Let Their Feet Lead the Way: Tools for Early Identification of FOP


share







 2021-03-03  22m
 
 

Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments


Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments


share







 2021-02-24  16m
 
 

GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!


GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!


share







 2021-02-17  19m
 
 

The First Biologic in IBD: When, Which, and Why?


The First Biologic in IBD: When, Which, and Why?


share







 2021-02-12  30m